Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 16NIH 7INDUSTRY 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 47Head & Neck 28Thoracic 26Gastrointestinal 20Genitourinary 10Breast 8Lymphoid 6Sarcoma 5Other 5Tumor-Agnostic 3Other solid neoplasm 2Other hematologic neoplasm 2Plasma cell 1Myeloid 1Gynecologic 1Dermatologic 1Classical hematology 1

Conditions

Solid Tumor, Adult 1Advanced Solid Tumors 1

Interventions

Injections 98pembrolizumab 90Carboplatin 57Paclitaxel 54Cisplatin 52Nivolumab 44Docetaxel 43Pemetrexed 42Gemcitabine 37atezolizumab 32tislelizumab 29Bevacizumab 29toripalimab 23Fluorouracil 23Capecitabine 23Irinotecan 22Oxaliplatin 20durvalumab 19Ipilimumab 18Leucovorin 17Cetuximab 17Rifampin 14Itraconazole 14olaparib 13spartalizumab 12Midazolam 12Cyclophosphamide 12trifluridine tipiracil drug combination 11sintilimab 11Drug Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Radiotherapy × Other solid neoplasm × Clear all
NCT04504942 2026-01-23

Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors

CytoDyn, Inc.

Phase 2 Completed
16 enrolled 16 charts
Other solid neoplasm

Solid Tumor, Adult

NCT06368960 2024-04-16

BM201-1001

InnoBM Pharmaceuticals Co., Ltd.

Phase 1 Unknown
36 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡